Immune Checkpoint Inhibitor-Mediated Aseptic Meningitis and Hypophysitis

Pavel Bleik1, Panisara Fangsaard1, Nataliya Yuklyaeva1

  • 1Department of Internal Medicine, Bassett Medical Center, Cooperstown, New York, USA.

Summary

Immune checkpoint inhibitors (ICIs) offer advanced cancer treatment but can cause immune-related adverse events. This case details aseptic meningitis and hypophysitis in a patient receiving ipilimumab and nivolumab, emphasizing careful monitoring.